OCCUDO QUANTITATIVE STRATEGIES LP - ENTASIS THERAPEUTICS HLDGS I ownership

ENTASIS THERAPEUTICS HLDGS I's ticker is ETTX and the CUSIP is 293614103. A total of 23 filers reported holding ENTASIS THERAPEUTICS HLDGS I in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
OCCUDO QUANTITATIVE STRATEGIES LP ownership history of ENTASIS THERAPEUTICS HLDGS I
ValueSharesWeighting
Q4 2021$51,000
-32.0%
23,221
+3.4%
0.01%
-44.4%
Q3 2021$75,000
+21.0%
22,457
-2.6%
0.01%0.0%
Q2 2021$62,0000.0%23,058
-20.6%
0.01%
-35.7%
Q1 2021$62,000
+72.2%
29,031
+101.0%
0.01%
+27.3%
Q4 2020$36,00014,4420.01%
Other shareholders
ENTASIS THERAPEUTICS HLDGS I shareholders Q1 2022
NameSharesValueWeighting ↓
Eventide Asset Management 590,602$1,577,0000.02%
TPG Group Holdings (SBS) Advisors, Inc. 1,020,748$2,725,0000.02%
OCCUDO QUANTITATIVE STRATEGIES LP 23,058$62,0000.01%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 110,000$294,0000.01%
Alberta Investment Management Corp 130,000$347,0000.00%
Jaffetilchin Investment Partners, LLC 11,000$29,0000.00%
TWO SIGMA INVESTMENTS, LP 164,229$438,0000.00%
TWO SIGMA ADVISERS, LP 162,942$435,0000.00%
Janney Montgomery Scott LLC 69,487$186,0000.00%
Renaissance Technologies 391,629$1,046,0000.00%
View complete list of ENTASIS THERAPEUTICS HLDGS I shareholders